SKI Market

A+| A| A-|

Indian Indices

Sensex

72,489.28 -1,093.94
( -1.49%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Everest Organics Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524790

INE334C01029

74.6694113

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

38.78

225.92

EPS(TTM)

Face Value()

Div & Yield %

Back

hindustan unilever ltd

Vaxfab Enterprises reports standalone net loss of Rs 2.25 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Vaxfab Enterprises reported to Rs 2.25 crore in the quarter ended September 2025 as against net loss of Rs 8.23 crore during the previous quarter ended September 2024. Sales rose 415.84% to Rs 55.04 crore in the quarter ended September 2025 as against Rs 10.67 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	55.04	10.67	416
OPM %	1.34	-75.73	-
PBDT	-2.68	-8.22	67
PBT	-2.69	-8.23	67
NP	-2.25	-8.23	73

72,489.28 -1,093.94 ( -1.49%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)